Back
Context Therapeutics Quote, Financials, Valuation and Earnings
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
66
CNTX
Context Therapeutics
Last Price:
2.30
Seasonality Move:
-29.9%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Context Therapeutics Price Quote
$2.30
+0.08 (+3.6%)
(Updated: September 20, 2024 at 11:20 AM ET)
Context Therapeutics Key Stats
Buy
66
Context Therapeutics (CNTX)
is a Buy
Day range:
$1.96 - $2.23
52-week range:
$0.77 - $2.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.65%
Volume:
38.1K
Avg. volume:
77.8K
1-year change:
136.17%
Market cap:
$166.5M
Revenue:
$0
EPS:
$-1.06
How Much Does Context Therapeutics Make?
Data Unavailable
Is Context Therapeutics Growing As A Company?
Data Unavailable
Context Therapeutics Stock Price Performance
-
Did Context Therapeutics Stock Go Up Last Month?
Context Therapeutics share price went down by -12.25% last month -
Did CNTX's Share Price Rise Over The Last Year?
CNTX share price rose by 136.17% over the past 1 year
What Is Context Therapeutics 52-Week High & Low?
-
What Is Context Therapeutics’s 52-Week High Share Price?
Context Therapeutics has traded as high as $2.75 over the past 52 weeks -
What Is Context Therapeutics’s 52-Week Low Share Price?
Context Therapeutics has traded as low as $0.77 over the past 52 weeks
Context Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Context Therapeutics?
-
How Much Debt Does Context Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Context Therapeutics Have?
Cash and short term investments quarterly total is $101.5M -
What Is Context Therapeutics’s Book Value Per Share?
Book value per share is 1.35
Is Context Therapeutics Cash Flow Positive?
-
What Is CNTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$18.4M -
What Is Context Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Context Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Context Therapeutics Return On Invested Capital
Data Unavailable
Context Therapeutics Earnings Date & Stock Price
-
What Is Context Therapeutics's Stock Price Today?
A single share of CNTX can be purchased today for 2.22 -
What Is Context Therapeutics’s Stock Symbol?
Context Therapeutics trades on the nasdaq under the ticker symbol: CNTX -
When Is Context Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Context Therapeutics is scheduled on November 29, 2024 -
When Is CNTX's next ex-dividend date?
Context Therapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Context Therapeutics Stock?
You can buy Context Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Context Therapeutics Competitors
-
Who Are Context Therapeutics's Competitors?
Below is a list of companies who compete with Context Therapeutics or are related in some way:
Context Therapeutics Dividend Yield
-
What Is CNTX Dividend Yield?
Context Therapeutics’s dividend yield currently is 0% -
What Is Context Therapeutics’s Payout Ratio?
Context Therapeutics’s payout ratio is 0% -
When Did Context Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Context Therapeutics’s Dividend Per Share?
Context Therapeutics pays a dividend of $0.00 per share
Context Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 40% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 7.63 |
| Upside from Last Price: | 243.47% |